Sachs Associates would like to say that we have enjoyed hosting you in person and virtually and thank those who participated in our Sachs Autumn Life Sciences Week, which incorporated the 1st Annual European Healthcare Impact Summit (#Sachs_EHIS) and the 26th Annual Biotech in Europe Forum (#Sachs_BEF). A special thank you goes to the excellent lineup of sponsors, chairs, panellists, exhibitors, and presenters who made such a broad and interesting programme possible and to those who participated in person and during the virtual week.
The Life Sciences Week has proven to be successful in supporting our community with 621 delegates from 27 countries and nearly 2500 in-person & online meetings completed.
Publicly available recordings of the sessions and presentations that took place during the event will be added once the event portal closes (after the 6th of November) on the SachsTV YouTube channel.
We are looking forward to welcoming you again at our future events!
BRONZE SPONSORS:
CONTRIBUTING SPONSORS:
Host City Sponsor:
RECEPTION SPONSOR:
Presenting Companies Included:
CheckBrain Therapeutics
Confirmed Keynote Speakers Included:
Jonathan Javitt
Founder & Chairman of GeNeuro, Inc, a Subsidiary, NRx Pharmaceuticals, Inc.
Stefan Loren
Managing Director, Healthcare Investment Banking, Oppenheimer & Co. Inc.
Stephan Brock
Managing Director, Lucera GmbH
Speakers and Chairs Included:
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
Allan Marchington
Managing Director, Head of Life Sciences, Intermediate Capital Group PLC
Anastasiya Sybirna
Principal, Jeito Capital
Anu Balendran
Head BD&L Transactions, CRM, Novartis Pharma AG
Audrey Cacaly
Principal, Forbion
Barbara Castellano
Partner, Panakès Partners SGR SpA
Birgit Steckel-Hamann
Associate VP, External Innovation, Search & Evaluation, Cardiometabolic Health, Eli Lilly and Company
Celine Bouquet
BD Head, Neuroscience, Ophthalmology & Rare Diseases, Basel, F. Hoffmann-La Roche AG
Chandra Leo
Investment Advisor, HBM Partners AG
Corinne Venot
VP, Global Business Development, BeOne Medicines I GmbH
Daniel Rankin
SVP, Head of Strategy & Corporate Development, Sobi
Daniel Marshall
Senior Director, BD&L, AstraZeneca
Davor Kosanic
CEO, Reconnect Labs AG
Eric Halioua
Executive Chairman, Ervimmune
Eric de la Fortelle
Head of Business Development & Strategy, Institute of Molecular & Clinical Ophthalmology Basel (IOB)
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Esther Melo
Senior Director BD&L, F. Hoffmann-La Roche AG
Evonne Sepsis
Managing Director, ESC Advisors
Fei Tian
Principal, MIG Capital AG
Florian Gerard-Mercier
Investment Director, Andera Partners SA
Georgia Frost
Vice President, Dementia Discovery Fund 2 L.P. (SV Health Investors)
Gerard Caelles
CBO, SpliceBio, S.L.
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Hannah England
Partner, Ropes & Gray LLP
Hemant Sabherwal
Head of Corporate Solutions & EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited (HKEX)
Hugh Nuthall
Executive Director, Search & Evaluation Neuroscience, Eli Lilly and Company
Indiana Wong
Director, Hong Kong Economic and Trade Office, Berlin (HKETO)
Ivana Labudovic
VP, Head of Pharmacovigilance & Chief Safety Officer, Organon
Jeremy Griggs
Executive Director, Search & Evaluation, GSK
Jerome Marzinski
CEO, OxSonics
Joachim Vogt
Director Search & Evaluation International, AbbVie, Inc.
Jonathan Tobin
Partner, Brandon Capital Partners
Julia Braun
Partner, Baker McKenzie
Julia Rossié
Counsel, Baker McKenzie
Katya Smirnyagina
Senior Partner, Oxford Science Enterprises
Kelly Curtin
Managing Director, Stifel
Khatereh Ahmadi
Venture Partner, XGEN Venture SGR S.p.A.
Konstantin von Schulthess
CFO, CDR-Life, Inc.
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Léa Perles
Associate Director & Strategic Operations, Brenus Pharma
Maria Dahl
Executive Director, BD&L, Novartis Pharma AG
Mark Bodmer
CEO, Nucleome Therapeutics Ltd.
Michael Bauer
Partner, Novo Holdings A/S
Michael Hübner
Director External Scientific Innovation, Johnson & Johnson Innovation LLC
Michael Altorfer
CEO, Swiss Biotech Association
Mohaned Shilaih
CEO, FimmCyte AG
Nate Chang
Advisor, Engineered Biology, Playground Global
Nigel Layton
Global Head of Life Sciences, Forvis Mazars
Nuno Alves
Business Development Lead, Astellas Pharma Europe Ltd.
Odile Rundquist
Partner, Bioqube Ventures
Peter Gergely
Global Head, Translational Medicine Immunology, Novartis BioMedical Research
Peter Louwagie
SVP Corporate & Business Development, Genmab A/S
Phil Masterson
Associate Director, Ventures, Cancer Research Horizons
Regina Hodits
Managing Director, Angelini Ventures S.p.A.
Renée Aguiar-Lucander
CEO, Hansa Biopharma AB
Sam Fazeli
Head of Research, Global Industries & Senior Pharmaceuticals Analyst, Bloomberg Intelligence
Samuel Hess
Co-Head of Economic Affairs, Canton of Basel-Stadt
Samuel Black
Senior Director, Global Business Development Neurology & Immunology, Merck KGaA
Sara Zhou
Co-Founder & Partner, Intercontinental Capital
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life, Inc.
Seth Goldblum
SVP - Corporate Development, Gyre Therapeutics, Inc.
Simone Sabbione
Co-Founder & CEO, Meliodays Medical GmbH
Stefan Luzi
Partner, Gilde Healthcare Partners BV
Stephan Emmerth
Director, BaseLaunch
Tamas Schweighoffer
Senior Advisor, Independent
Thibaut Roulon
Senior Investment Director, Bpifrance
Tord Labuda
CEO, Alzinova AB
Torsten Madsen
CEO, IAMA Therapeutics S.r.l.
Ulf Grawunder
Founder & CEO, T-CURX GmbH
Ulrich Platte
CFO, Anaveon AG
Vanessa Carle
Principal, Forbion
Winsome Cheung
Partner, Covington & Burling LLP
Zhizhong (Joel) Yao
Partner, Sofinnova Partners